This article has been corrected: Due to errors in image assembly, the flow cytometry profiles depicting the isotype matched control (IMC) for CD49f on both scramble (scr) and miR-100 reported in Figure 6 are incorrect. Additionally, we noticed that the IMC reported for CD24 and CD10 in miR-100 are the same. Being both CD24 allophycocianin (APC) and CD10 APC IgG1, they should have the same IMC, as already reported. The corrected Figure 6 is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.
Petrelli, A., Carollo, R., Cargnelutti, M., Iovino, F., Callari, M., Cimino, D., et al. (2019). Erratum: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy. ONCOTARGET, 10(48), 5003-5004 [10.18632/oncotarget.27151].
Erratum: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy
Carollo, Rosachiara;Iovino, Flora;Cimino, Daniela;Todaro, Matilde;Mangiapane, Laura Rosa;Giammona, Alessandro;Cordova, Adriana;Stassi, Giorgio;Giordano, Silvia
2019-01-01
Abstract
This article has been corrected: Due to errors in image assembly, the flow cytometry profiles depicting the isotype matched control (IMC) for CD49f on both scramble (scr) and miR-100 reported in Figure 6 are incorrect. Additionally, we noticed that the IMC reported for CD24 and CD10 in miR-100 are the same. Being both CD24 allophycocianin (APC) and CD10 APC IgG1, they should have the same IMC, as already reported. The corrected Figure 6 is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.File | Dimensione | Formato | |
---|---|---|---|
oncotarget-10-5003PETRELLI correction.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
1.46 MB
Formato
Adobe PDF
|
1.46 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.